Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia.
Opthea stock last closed at $3.29, down 1.65% from the previous day, and has decreased 18.51% in one year. It has overperformed other stocks in the Biotechnology industry by 0.03 percentage points. Opthea stock is currently +105.31% from its 52-week low of $1.60, and -25.34% from its 52-week high of $4.40.
There are currently 467.16M shares of OPT outstanding. The market capitalization of OPT is $191.83M. In the past 24 hours, 1352 OPT shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy OPT shares.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal info so you are able to buy OPT stock today.
Now that you've filled out your info on investing apps, you can securely and quickly fund your account:
Watch the video below for more details transferring money into your brokerage account.
After you have chosen the best place to buy Opthea stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk and upside.
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on OPT's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge OPT's intrinsic value.
You can access additional valuation analysis on OPT's stock here.
You can dig deeper into what analysts are projecting on the Opthea stock forecast page.
Last year, OPT revenue was $385.28k. Over the last 4 year, OPT's revenue has grown by -14.2% per year. This was slower than the Biotechnology industry average of 28.49%.
Dig into OPT's earnings and revenue performance here.
Over the last 12 months, executives and large shareholders at OPT have not bought or sold any shares.
Research more about who owns OPT shares here.
No, Opthea doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main order types:
Click the Open button and your broker will place the order.
If you require additional assistance buying stocks on eToro, click the helpful video below:
Now that you own some OPT shares, you'll want to stay up-to-date on your investment.
Make a watchlist to track your OPT stock.
To reiterate, here are the 6 steps for buying Opthea stock:
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your investment in Opthea, create a watchlist on WallStreetZen today.